The transcranial pulse stimulation (TPS®) as a method in the treatment of the central nervous system of patients with Alzheimer`s dementia

Recruiting

• Conditions: F00; Dementia in Alzheimer disease

• Registration Number: DRKS00033282
• Lead Sponsor: Wahrendorff Klinikum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-01-24
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Main Diagnosis: Alzheimer's Disease

Exclusion Criteria

Other Main Diagnosis than Alzheimer's Disease

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Development of cognitive performance (assessed by MOCA) and depressive symptom burden (assessed by GDS) during TPS treatment, follow-up design. The data from patients with AD are collected at the beginning of treatment (t1) and then every three months during the course of treatment until a point in time of at least four follow-up measurements (t2 = after 3 months, t3 = after 6 months, t4 = after 9 months, t5 = after 12 months).

Secondary Outcome Measures

Name	Time	Method
Patients' personal experience/assessment of TPS-treatment (assessed by questionnaire), follow-up design. The data from patients with AD are collected at the beginning of treatment (t1) and then every three months during the course of treatment until a point in time of at least four follow-up measurements (t2 = after 3 months, t3 = after 6 months, t4 = after 9 months, t5 = after 12 months).